The Increased Risk for Postinfluenza Pneumonia Among Cystic Fibrosis Carriers—A Population-Based Study - Top-Institutions - MDSpire

The Increased Risk for Postinfluenza Pneumonia Among Cystic Fibrosis Carriers—A Population-Based Study

  • By

  • Aaron C Miller

  • D Erik Boonstra

  • Joe E Cavanaugh

  • Mahmoud H Abou Alaiwa

  • Alejandro P Comellas

  • Douglas B Hornick

  • David A Stoltz

  • Philip M Polgreen

  • October 23, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Cystic Fibrosis Foundation Therapeutics
    Cystic Fibrosis Foundation Therapeutics

    Bethesda, MD

    Key Differentiators

    • Cystic Fibrosis Research
    • Pulmonology
    • Infectious Diseases

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Pulmonology
    • Infectious Diseases
    • Genetics

  • #3

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Pulmonology
    • Epidemiology
    • Infectious Diseases

  • #4

    University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill

    Chapel Hill, NC

    Key Differentiators

    • Pulmonology
    • Cystic Fibrosis
    • Infectious Diseases

  • #5

    Seattle Children's Research Institute
    Seattle Children's Research Institute

    Seattle, WA

    Key Differentiators

    • Pediatric Pulmonology
    • Cystic Fibrosis
    • Infectious Diseases

Original Source(s)

The Increased Risk for Postinfluenza Pneumonia Among Cystic Fibrosis Carriers—A Population-Based Study

  • by Aaron C Miller, D Erik Boonstra, Joe E Cavanaugh, Mahmoud H Abou Alaiwa, Alejandro P Comellas, Douglas B Hornick, David A Stoltz, Philip M Polgreen

  • October 23, 2025

Related Content

Association of Systemic Inflammatory Markers with 28-Day Mortality in Patients with Severe Pneumonia: A Retrospective Study from a Single Center

Viral, Fungal Infections May Contribute to Nonresolving ARDS

Review links viral and fungal infections to persistent lung injury in nonresolving ARDS

Rapid AST Speeds Care, Not Outcomes

Faster antibiotic optimization may still support use of rapid testing, particularly when paired with stewardship.